IDEX Biometrics ASA
IDXAD
$0.20
$0.10100.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 104.00K | 24.00K | 58.00K | 385.00K | 372.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 104.00K | 24.00K | 58.00K | 385.00K | 372.00K |
| Cost of Revenue | 86.00K | 1.19M | 28.00K | 233.00K | 237.00K |
| Gross Profit | 18.00K | -1.16M | 30.00K | 152.00K | 135.00K |
| SG&A Expenses | 889.00K | 1.26M | 1.86M | 2.53M | 3.15M |
| Depreciation & Amortization | 138.00K | 1.41M | -372.00K | 1.10M | 382.00K |
| Other Operating Expenses | 1.56M | 2.25M | 1.20M | 1.86M | 1.97M |
| Total Operating Expenses | 3.22M | 5.94M | 4.11M | 6.36M | 6.33M |
| Operating Income | -3.11M | -5.92M | -4.05M | -5.98M | -5.96M |
| Income Before Tax | -4.14M | -3.84M | 1.36M | -6.67M | -5.42M |
| Income Tax Expenses | 2.00K | -122.00K | -- | 2.00K | -- |
| Earnings from Continuing Operations | -4.14M | -3.72M | 1.36M | -6.67M | -5.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.14M | -3.72M | 1.36M | -6.67M | -5.42M |
| EBIT | -3.11M | -5.92M | -4.05M | -5.98M | -5.96M |
| EBITDA | -3.06M | -5.58M | -3.82M | -4.88M | -5.73M |
| EPS Basic | -0.50 | -0.70 | 0.43 | -2.29 | -1.94 |
| Normalized Basic EPS | -0.01 | -0.45 | -0.10 | -1.43 | -1.21 |
| EPS Diluted | -0.50 | -0.70 | 0.43 | -2.29 | -2.00 |
| Normalized Diluted EPS | -0.01 | -0.45 | -0.10 | -1.43 | -1.21 |
| Average Basic Shares Outstanding | 8.32M | 5.28M | 3.13M | 2.92M | 2.80M |
| Average Diluted Shares Outstanding | 8.32M | 5.28M | 3.14M | 2.92M | 2.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |